Jounce Therapeutics, Inc.
JNCEDelisted May 4, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640455
Jounce Therapeutics, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on May 5, 2023; 84 institutions reported holding it in 13F filings for Q1 2023, worth $64.1M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Jounce Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Jounce Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Tang Kevin C | Director, 10% Owner | 10,000Indirect | May 5, 2023 | 0 |
| Tang Capital Partners LP | 10% Owner | 10,000Indirect | May 5, 2023 | 0 |
| Tang Capital Management LLC | 10% Owner | 10,000Indirect | May 5, 2023 | 0 |
| Concentra Biosciences, LLC | 10% Owner | 10,000 | May 5, 2023 | 0 |
| Murray Richard | Director | 1 | May 4, 2023 | 0 |
| Karsen Perry A | Director | 0 | May 4, 2023 | 0 |
| Drapkin Kimberlee C | President, CFO and Treasurer | 0 | May 4, 2023 | 0 |
| Duncan Barbara Gayle | Director | – | May 4, 2023 | 0 |
| Kamen Robert | Director | 0Indirect | May 4, 2023 | 0 |
| Diaz Luis | Director | – | May 4, 2023 | 0 |
| Iannone Robert | Director | – | May 4, 2023 | 0 |
| Raythatha Jigar | Director | – | May 4, 2023 | 0 |
| Salter-Cid Luisa | Director | – | May 4, 2023 | 0 |
| Cole Hugh M | Chief Operating Officer | 110,082 | Jan 11, 2023 | 0 |
| Trehu Elizabeth | Chief Medical Officer | 103,417 | Jan 11, 2023 | 0 |
| Higgons John Duncan | Director | – | Jun 28, 2022 | 0 |
| Levin Mark J | 10% Owner | 1,148,780 | Nov 16, 2021 | 0 |
| Tepper Robert I | 10% Owner | 1,148,780 | Nov 16, 2021 | 0 |
| Starr Kevin P | 10% Owner | 1,148,780 | Nov 16, 2021 | 0 |
| Third Rock Ventures III, L.P. | 10% Owner | 1,148,780 | Nov 16, 2021 | 0 |
| TRV GP III, LLC | 10% Owner | 1,148,780 | Nov 16, 2021 | 0 |
| Third Rock Ventures GP III, L.P. | 10% Owner | 1,148,780 | Nov 16, 2021 | 0 |
| Pfeffer Cary | Director | 0Indirect | Nov 16, 2021 | 0 |
| Third Rock Ventures II, L.P. | 10% Owner | 2,697,829 | Sep 17, 2021 | 0 |
| Third Rock Ventures GP II, L.P. | 10% Owner | 2,697,829 | Sep 17, 2021 | 0 |
| TRV GP II, LLC | 10% Owner | 2,697,829 | Sep 17, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Murray RichardDirector | SSale | −39.2K | $1.85 | −$72.6K | −17.2%188.8K after | 10b5-1 |
| Mar 14, 2023 (view filing)8:39 PM ET | Mar 13-14 | 1 day | Tang Kevin C and 2 others10% Owner | PPurchase | +86.0K | $0.9997 | +$86.0K | +1.6%5.30M after | 2 lots |
| Jan 11, 2023 (view filing) | Jan 9-10 | 2 days | Trehu ElizabethChief Medical Officer | SSale | −9.29K | $1.11 | −$10.3K | −8.2%103.4K after | 2 lots |
| Jan 11, 2023 (view filing) | Jan 9-10 | 2 days | Murray RichardCEO and President | SSale | −45.1K | $1.11 | −$50.1K | −16.5%228.0K after | 2 lots |
| Jan 11, 2023 (view filing) | Jan 9-10 | 2 days | Drapkin Kimberlee CCFO and Treasurer | SSale | −14.1K | $1.11 | −$15.7K | −17.6%66.0K after | 2 lots |
| Jan 11, 2023 (view filing) | Jan 9-10 | 2 days | Cole Hugh MChief Operating Officer | SSale | −16.6K | $1.11 | −$18.5K | −13.1%110.1K after | 2 lots |
| Jan 11, 2022 (view filing) | Jan 7-10 | 4 days | Trehu ElizabethChief Medical Officer | SSale | −8.38K | $6.88 | −$57.7K | −9.0%85.2K after | 2 lots |
| Jan 11, 2022 (view filing) | Jan 7-10 | 4 days | Murray RichardCEO and President | SSale | −37.3K | $6.88 | −$256.7K | −16.7%185.6K after | 2 lots |
| Jan 11, 2022 (view filing) | Jan 7-10 | 4 days | Drapkin Kimberlee CCFO and Treasurer | SSale | −12.8K | $6.88 | −$88.2K | −19.6%52.6K after | 2 lots |
| Jan 11, 2022 (view filing) | Jan 7-10 | 4 days | Cole Hugh MChief Business Officer | SSale | −9.67K | $6.88 | −$66.6K | −13.1%64.2K after | 2 lots |
| Nov 16, 2021 (view filing)7:57 PM ET | Nov 12 | 4 days | Levin Mark J and 5 others10% Owner | SSale | −1.90M | $8.38 | −$15.9M | −62.3%1.15M after | |
| Nov 16, 2021 (view filing) | Nov 12 | 4 days | Pfeffer CaryDirector | SSale | 0 | – | $0 | –0 after |